Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Oct:45:102392.
doi: 10.1016/j.msard.2020.102392. Epub 2020 Jul 12.

COVID-19 in MS and NMOSD: A multicentric online national survey in Chile

Ethel Ciampi  1 , Reinaldo Uribe-San-Martín  2 , Bernardita Soler  2 , Ramiro Fernández  3 , Pía García  4 , Claudio Navarrete-Asenjo  5 , José Miguel Tirapegui  6 , Rubén Torres  7 , Juan Polanco  8 , Felipe Suárez  9 , María José Cuello  10 , Claudia Cárcamo  11
Affiliations
Multicenter Study

COVID-19 in MS and NMOSD: A multicentric online national survey in Chile

Ethel Ciampi et al. Mult Scler Relat Disord. 2020 Oct.
No abstract available

Keywords: COVID-19; Disease-modifying therapy; Immunotherapy; Multiple sclerosis; Nmosd.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest EC received the ECTRIMS Clinical Fellowship (2013–2014), ECTRIMS travel grant awards, and academic travel support from Novartis, Genzyme, Merck, Biogen and Roche, has been a member of advisory boards at Genzyme, Biogen, Merck and Novartis, has received sub-investigator fees from the ISS “Social Cognition in MS” project at Teva. RUSM received academic travel support from Novartis, Genzyme, Merck, Biogen andRoche, has been a member of advisory boards at Genzyme, Biogen, Merck and Novartis. BS received academic travel support from Novartis, Teva, Merck and Biogen RF received academic travel support from Genzyme, Biogen, Merck, Novartis, Roche, Teva and speaker compensations from Teva and Biogen. PG nothing to disclose CN received academic travel support from Biogen, Genzyme, Novartis and Merck JMT nothing to disclose RT received academic travel support from Biogen, Roche, Teva, Sanofi, Novaris and Merck JP received academic travel support from Biogen, Novartis, Genzyme, Merck and Roche FS nothing to disclose MJC nothing to disclose CC received academic travel support from Novartis, Genzyme, Merck, Biogen and Roche, has been a member of advisory boards at Genzyme, Biogen, Merck and Novartis, has received PI fees from the ISS “Social Cognition in MS” project at Teva.

References

    1. Bowen J.D., Brink J., Brown T.R. COVID-19 in MS: initial observations from the Pacific Northwest. Neurol. Neuroimmunol. Neuroinflamm. 2020;7(5):e783. doi: 10.1212/NXI.0000000000000783. Published 2020 May 26. - DOI - PMC - PubMed
    1. Brownlee W., Bourdette D., Broadley S., Killestein J., Ciccarelli O. Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic. Neurology. 2020;94(22):949–952. doi: 10.1212/WNL.0000000000009507. - DOI - PubMed
    1. Ciampi E., Uribe-San-Martin R., Cárcamo C. COVID-19 pandemic: the experience of a multiple sclerosis centre in Chile [published online ahead of print, 2020 May 16] Mult. Scler. Relat. Disord. 2020;42 doi: 10.1016/j.msard.2020.102204. - DOI - PMC - PubMed
    1. Fernández R. In: Arriagada C., Nogales-Gaete y J., editors. Demos Medical Publishing; New York: 2008. Editores.
    1. Louapre C., Collongues N., Stankoff B. Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis. JAMA Neurol. 2020 doi: 10.1001/jamaneurol.2020.2581. [published online ahead of print, 2020 Jun 26] - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources